1
2
3
Exhibit 10.1
PERFORMANCE SHARE UNIT TERMS UNDER THE
MERCK & CO., INC. 2004 INCENTIVE STOCK PLAN
Except as otherwise indicated in
this schedule, the terms of Performance Shares granted under this
Schedule are the same as those described in the Rules and
Regulations. Except as defined below, defined terms under this
Schedule are the same as under the Rules and
Regulations.
I. Definitions
For the purpose of this
Schedule:
“Award Period” shall mean three
years, with the first Award Period commencing on January 1,
2004 and ending December 31, 2006. The next Award Period also
shall be three years, commencing January 1, 2005.
“Final Award Percentage” for each
Award Period shall mean the percentage of Target described in
Article IV.
“Grant Date” shall mean the date a
Performance Share Award is granted, and shall not be later than
90 days after the beginning of an Award Period with respect to
that Award Period.
“Leading Healthcare Peers” shall
mean the group of healthcare companies used by the Board of
Directors in evaluating the Company’s annual performance for
that year.
“Leading Healthcare Peers Earnings Per
Share” for a Year shall mean the change in Earnings Per Share
for each Leading Healthcare Peer from the prior year using the same
method applicable to the Board’s evaluation of the
Company’s annual performance; provided, however, that the
calculation shall be as of the most reasonably practicable date
prior to the date on which the Earnings Per Share is
calculated.
“Performance Award Grantee” shall
mean an Eligible Employee who receives a Performance Share Award as
described in Article II.
“Performance Share Award” shall mean
an award of Performance Shares as described in this
Schedule.
“Performance Measure” shall mean the
change in the Company’s Earnings Per Share for a Year and
each Leading Healthcare Peers Earnings Per Share for the same Year
to the extent data for the same Year is available.
“Performance Share” shall mean a
phantom share of Merck Common Stock. Until distributed pursuant to
Article VII, Performance Shares shall not entitle the holder
to any of the rights of a holder of Merck Common Stock; provided,
however, that the Committee retains the right to make adjustments
in the case of a corporate restructuring as described in
Section 6 of the ISP.
“Target Shares” shall mean the
number of Performance Shares that will be distributable if the
Performance Measures are achieved at the 6 th of 12
Final Ranks as described in Article IV.
“Year” means calendar
year.
II. Eligibility
Each
Eligible Employee who also is a Grade 1 or Grade 2 employee on the
Grant Date is eligible to receive Performance Shares if the
Committee, in its sole and non-reviewable discretion, designates
him or her to receive a Performance Share Award (“Performance
Award Grantee”).
III. Establishment of
Targets
The
Committee, in its sole and non-reviewable discretion, shall
determine the Target Shares for each Performance Share Award for
each Performance Award Grantee.
IV. Determination of
Performance Share Awards
The
Committee expects that there will be 11 Leading Healthcare Peers
for each Award Period.
For
each Year, the Performance Measure shall be calculated for the
Company and each Leading Healthcare Peer. Each Leading Healthcare
Peer and the Company shall then be assigned a rank
(“Rank”) from one to 12, highest to lowest Performance
Measure, as appropriate.
After
the end of the Award Period, the Ranks of each Leading Healthcare
Peer and the Company for all Years within the Award Period shall be
averaged, and the averages shall then be ranked (the “Final
Rank”) from one (the highest rank) to 12 (the lowest rank),
as appropriate.
The
Final Award Percentage shall be the following percentage of Target
Shares based on the Company’s Final Rank for an Award
Period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2
|
|
|
|
3
|
|
|
|
4
|
|
|
|
5
|
|
|
|
6
|
|
|
|
7
|
|
|
|
8
|
|
|
|
9
|
|
|
|
10
|
|
|
|
11
|
|
|
|
12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
180
|
%
|
|
|
160
|
%
|
|
|
140
|
%
|
|
|
120
|
%
|
|
|
100
|
%
|
|
|
80
|
%
|
|
|
60
|
%
|
|
|
40
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If at
any time the number of Leading Healthcare Peers is not 11, the
Committee intends to adjust the above schedule appropriately to
retain a similar range of Performance Share Award opportunities
with a maximum Final Award Percentage of 200% and a minimum of 0%.
The Committee also intends that, in case of multiple changes in the
Leading Healthcare Peer group during an Award Period, replacement
companies shall be substituted based on the substitutes’
market capitalization relative to the other Leading Healthcare Peer
group.
Notwithstanding the above, for the Award Period
commencing January 1, 2005 and ending December 31, 2007
(the “Special Award Period”), the Rank of the Company
with respect to the first Year only shall not be based on a
comparison to the Leading Healthcare Peers Earnings Per Share but
instead be based on the Company’s earnings per share against
business plan. [Pre-determined targets established by Company
omitted.]
The
Rank of each Leading Healthcare Peer for the first Year of the
Special Award Period shall be determined using the Performance
Measure except that each Leading Healthcare Peer with a Rank that
is equal to or lower than the Company’s Rank for the first
Year will instead assume a Rank that is one Rank lower than its
Rank using the Performance Measure. [Reference to pre-determined
targets established by Company omitted.] All Leading Healthcare
Peers with Ranks from one to five for the first Year using the
Performance Measure will retain their Ranks; the Leading Healthcare
Peers with Ranks from six to 11 will instead assume Ranks from
seven to 12, respectively. The Company intends that grants be
deductible by the Company under Section 162(m) of the Internal
Revenue Code and reserves the right to make such adjustments as may
be required